Lasika Seneviratne

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial

Hope S. Rugo, Lasika Seneviratne, J. Thaddeus Beck et al. · The Lancet Oncology · 2017 · 211 citations

Breast Oncology, Medicine, Gynecology +7

Evolving characteristics of AIDS-related lymphoma

Alexandra M. Levine, Lasika Seneviratne, Byron M. Espina et al. · Blood · 2000 · 159 citations

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 78 citations · Full text

Nivolumab Versus Docetaxel, Medicine, Pharmacology +7

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

Fabrice Barlési, Makoto Nishio, Manuel Cobo et al. · Annals of Oncology · 2018 · 49 citations

Key Subgroups, Oncology, Medicine +6

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)

David R. Spigel, Robert M. Jotte, John Nemunaitis et al. · Journal of Thoracic Oncology · 2020 · 48 citations · Full text

Medicine, Pharmacology, Immune Checkpoint Inhibitor +8